Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PEPTONIC medical ABXSAT:PMED Receivables Turnover is 0.00 as of Mar. 2026. The stock has 6 warning signs investors should review. Among 951 Drug Manufacturers companies, PEPTONIC medical AB ranks worse than 105152.37% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. PEPTONIC medical AB's Revenue for the
three
months ended in Mar. 2026 was kr3.14 Mil. PEPTONIC medical AB's average Accounts Receivable for the
three
months ended in Mar. 2026 was kr0.00 Mil.
PEPTONIC medical AB (XSAT:PMED) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
PEPTONIC medical AB Receivables Turnover Related Terms
PEPTONIC medical AB Receivables Turnover Historical Data
* Premium members only.
The historical data trend for PEPTONIC medical AB's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:PMED vs ZTS, UTHR, VTRS: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PEPTONIC medical AB Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where PEPTONIC medical AB's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PEPTONIC medical AB (XSAT:PMED) has a Receivables Turnover of 0.00 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PEPTONIC medical AB and its competitors. According to the industry distribution chart, PEPTONIC medical AB ranks #999999 out of 951 companies in the Drug Manufacturers industry.
Is PEPTONIC medical AB's Receivables Turnover too high?
PEPTONIC medical AB's current Receivables Turnover is 0.00. Based on the distribution chart, PEPTONIC medical AB ranks #999999 out of 951 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does PEPTONIC medical AB's Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PEPTONIC medical AB ranks #999999 out of 951 companies for Receivables Turnover. This places PEPTONIC medical AB in the lower half of its industry. The industry median Receivables Turnover is 5.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 951 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PEPTONIC medical AB and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PEPTONIC medical AB's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PEPTONIC medical AB stock overvalued right now?
PEPTONIC medical AB (XSAT:PMED) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For PEPTONIC medical AB (XSAT:PMED), the current Receivables Turnover is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:PMED has been successfully added to your 
